RxDoctor Payments Data

Jesse Meaike, MD

Hand Surgery · Norfolk, NENPI 1164956728

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Axogen at 26.3% of the total. Reporting peaked in 2023 at $1,426 and has fallen 59.1% since, to $584 in 2025. Among hand surgery clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,201in general payments, 2019–2025

Across 47 payments — averaging $110.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$1K
  • Medical Device Business Services, Inc.$1K
  • Integra Lifesciences Corporation$649
  • AbbVie$360
  • Trimed, Inc.$350
  • Checkpoint Surgical, Inc$287
  • plus $1K from 12 others

What the payments were for

  • Travel & lodging$1,17623%
  • Food & beverage$2,55349%
  • Education$1,14722%
  • Other$3256%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,201 in reported general payments places this provider in the 90th percentile of 21 hand surgery providers in Nebraska.

See all hand surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$26,595
Medicare patients
48
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl64$164
Ondansetron OdtOndansetron23$87

Paid to pharmacies, not to this prescriber.

Other hand surgery in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →